Remember meForgot password?
    Log in with Twitter

Pharmaceuticals News

Global drug spending set to rise to $1.4 trillion

In news that will no doubt please the shareholders of pharmaceutical companies, the global spend on drug products is set to rise by 30 percent by the year 2020. This means an annual pay-out of $1.4 trillion.

Many pharma companies failing the clinical trials test

London - The Good Pharma Scorecard is a system that ranks drugs based on their transparency and ethical practices. A review of some big pharma companies reveals several inconsistencies.

FDA blocks imports from Megafine Pharma

The U.S. Food and Drug Administration (FDA) has placed an import ban on the drug maker Megafine Pharma's Nashik site in Maharashtra, India.

Time to get clean on pharma pollution?

Most countries do not have any legal limits for the control of pollution from drugs during their manufacture, use and disposal. Some people are now calling for urgent action.

Has Turing Pharmaceuticals violated antitrust rules?

An investigation has been initiated in New York to see whether Turing Pharmaceuticals has contravened antitrust rules by restricting distribution of the drug Daraprim, as a means to block generic competition.

Roche in $580 pharma acquisition

Swiss drug giant Roche is to acquire rival company Adheron Therapeutics for $580 million. Adheron Therapeutics are based in the U.S.

Pharma company criticized over pigeons in process area

Mumbai - Pan Drugs Limited of Nandesari, India has been cited by the U.S. FDA for evidence of pigeons in an area of a drug manufacturing facility used to process medications.

Polydrug Laboratories banned from importing to U.S.

Mumbai - The company Polydrug Laboratories is no longer able to import medicinal products into the U.S. following a series of concerns about manufacturing standards.

Research companies pair up to tackle antibiotic resistance

London - As part of the growing action against the progressive rise in antibiotic resistant bacteria, two R&D organizations are to work together with the aim of creating new antibiotics.

Op-Ed: Global drug imports from India need better standards

Mumbai - The Indian pharmaceutical sector is beset with compliance problems. This is demonstrated via a series of import bans into the U.S. imposed by the U.S. Food and Drug Administration (FDA).

Pharmaceutical industry news round-up

Digital Journal delves into the key pharmaceutical sector business news. This week we bring updates from Novartis, Bayer, Boehringer and Lilly.

Amgen fined in the U.S. over 'improper advertising'

The pharmaceutical company Amgen has been fined by U.S. authorities in relation to the advertising of its products. The settlement is $71 million.

Is pharmaceutical waste triggering antibiotic resistance?

Several pharmaceutical companies have been accused by a campaign organization of contributing to the rise of antibiotic resistance among types of pathogenic bacteria, the so-termed "super bugs."

Big Pharma: Teva bids $40 billion for Mylan

Israel-based pharmaceutical company Teva makes an unsolicited offer for a smaller, Netherlands-based rival called Mylan, as its main product faces competition from generics.

AbbVie in major pharma acquisition

The pharmaceutical company AbbVie beat out a range of other major pharmaceutical firms, including global giant Johnson & Johnson, to reach a $21 billion deal with cancer drug specialist Pharmacyclics.

Pfizer to acquire Hospira in big pharma sale

The pharmaceutical Pfizer giant is purchasing the injectable drugmaker Hospira for a reported $15 billion. This represents a new area for Pfizer.

Merck buys Cubist Pharmaceuticals

Major pharmaceutical company Merck has splashed out $8 billion on a smaller company called Cubist Pharmaceuticals. This is related to the search for new antibiotics.

Drug companies hacked by FIN4

Cyberspies have reportedly hacked into the emails of a number of publicly traded companies. Most of these operate in health care and pharmaceuticals.

GlaxoSmithKline continues restructuring, cuts 900 jobs

GlaxoSmithKline (GSK) is eliminating 900 U.S. jobs. Most of these losses are in R&D. Furthermore, some employees may be relocated to other facilities.

Typical drug development costs $2.6 billion

How much does it cost to produce a pharmaceutical product these days? According to a new study, the typical cost has rocketed to $2.6 billion. The $ figure is up from an estimated price tag of $1 billion from an analysis published in 2003.

Merck buys Sigma-Aldrich for $17 billion

The German drug maker Merck has acquired the U.S.-based science supply company Sigma-Aldrich in a multi-billion-dollar deal. Merck has been growing its laboratory supply side and it has now become one of the biggest companies in the business.

Glaxo receives record fine in China

Changsha - The Chinese government has fined U.K. pharmaceuticals giant GlaxoSmithKline $490 million (3 billion yuan) after a court found the firm guilty of bribery.

Leading pharmacists debate hospital infections Special

Warwick - This week the leading pharmacists in the U.K. congregated in Warwick for the NHS QA Symposium. A number of measures to protect patients from infection were discussed, and Digital Journal was in attendance.

New cardiac drug shows real, life-saving promise

Basel - A new drug developed by Swiss pharmaceutical giant Novartis could turn the world of cardiovascular medicine on its head in less than 12 months.

Rotting frogs found in pharmaceutical plant

During an inspection of Marck Biosciencies' plant in Kheda, India, the U.S. FDA found faked data, mold and rotting frogs.

Pomegranate candidate in quest for Alzheimer’s cure

Huddersfield - The onset of Alzheimer's can be slowed and some symptoms reduced by a natural compound found in pomegranate fruit. Those are the preliminary findings of a two year study undertaken by researchers at the University of Huddersfield in the UK.

AbbVie buys Shire for $54 billion

London - The purchase of pharmaceutical company Shire by AbbVie will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.

Op-Ed: Sometimes fatal side-effects to be revealed after Tor. Star probe

After an ongoing Toronto Star investigation exposed the fact that Health Canada was scrubbing crucial information from public view, the federal regulator will make public information it has kept secret regarding serious, sometimes fatal side-effects.

U.S. DEA cracks down on synthetic drugs

This week DEA agents launched raids in 29 U.S. states, making more than 150 arrests and serving 200 warrants, while also seizing more than $20 million in cash and assets in relation to synthetic drugs.

Did the Mafia snatch pharma drugs consignment?

Italian law enforcement has reported that a highly organized criminal ring is behind the distribution of stolen and counterfeit cancer drugs throughout Western Europe. Is it the Italian mafia?
  1 2 Next»

Set up a news alert for


Pharmaceuticals Image

A variety of statin drugs
A variety of statin drugs
Dr. Olumayokun Olajide s research will now look to produce compound derivatives of punicalagin for a...
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's
University of Huddersfield
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
Alexion Pharmaceuticals
Medicine vials on display at making Pharmaceuticals 2015.
Medicine vials on display at making Pharmaceuticals 2015.
Biogen is an American global biotechnology company based in Cambridge  Massachusetts  specializing i...
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Project Team at work:  Expertise helps AbbVie develop and enhance products and therapies to treat co...
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer.
© AbbVie Inc.
Eli Lilly s global headquarters  Indianapolis  Indiana
Eli Lilly's global headquarters, Indianapolis, Indiana
Sativex contains marijuana-derived ingredients.
Sativex contains marijuana-derived ingredients.
Associated Press